Ganaway, Carlito B.
HRN: 26-00-58 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/15/2024
10/21/2024
IVTT
1.5 G
Q6
Sepsis, Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes